MicroRNA Profiling Implies New Markers of Gemcitabine Chemoresistance in Mutant p53 Pancreatic Ductal Adenocarcinoma

Background: No reliable predictors of susceptibility to gemcitabine chemotherapy exist in pancreatic ductal adenocarcinoma (PDAC). MicroRNAs (miR) are epigenetic gene regulators with tumorsuppressive or oncogenic roles in various carcinomas. This study assesses chemoresistant PDAC for its specific m...

Verfasser: Dhayat, Sameer
Mardin, Wolf Arif Mithat
Seggewiß, Jochen
Ströse, Anda Jana
Matuszcak, Christiane
Hummel, Richard
Senninger, Norbert
Mees, Sören Torge
Haier, Jörg
FB/Einrichtung:FB 05: Medizinische Fakultät
Dokumenttypen:Artikel
Medientypen:Text
Erscheinungsdatum:2015
Publikation in MIAMI:14.04.2016
Datum der letzten Änderung:31.07.2020
Angaben zur Ausgabe:[Electronic ed.]
Quelle:PLoS ONE 10 (2015) 11, e0143755, 1-21
Fachgebiet (DDC):610: Medizin und Gesundheit
Lizenz:CC BY 4.0
Sprache:English
Anmerkungen:Finanziert durch den Open-Access-Publikationsfonds 2015/2016 der Westfälischen Wilhelms-Universität Münster (WWU Münster).
Format:PDF-Dokument
ISSN:1932-6203
URN:urn:nbn:de:hbz:6-76229530002
Weitere Identifikatoren:DOI: 10.1371/journal.pone.0143755
Permalink:https://nbn-resolving.de/urn:nbn:de:hbz:6-76229530002
Onlinezugriff:journal.pone.0143755.PDF
LEADER 03973cam a2200445uu 4500
001 8d7366b3-72ba-41ad-8654-0cc02ab7b687
003 miami
005 20200731
007 c||||||||||||a|
008 160414e20160414||||||||||#s||||||||eng||||||
022 |a 1932-6203 
024 7 |a urn:nbn:de:hbz:6-76229530002  |2 urn 
024 7 |a 10.1371/journal.pone.0143755  |2 doi 
041 |a eng 
082 0 |a 610 Medizin und Gesundheit  |2 23 
100 1 |a Dhayat, Sameer  |0 http://d-nb.info/gnd/130109711  |0 https://orcid.org/0000-0002-5314-9736  |0 http://viaf.org/viaf/40474003  |0 http://isni.org/isni/0000000021201005  |4 aut 
110 2 |a Universitäts- und Landesbibliothek Münster  |0 http://d-nb.info/gnd/5091030-9  |4 own 
245 1 0 |a MicroRNA Profiling Implies New Markers of Gemcitabine Chemoresistance in Mutant p53 Pancreatic Ductal Adenocarcinoma 
250 |a [Electronic ed.] 
264 1 |c 2015-11-25 
264 2 |b Universitäts- und Landesbibliothek Münster  |c 2016-04-14 
300 |a 1-21 
500 |a Finanziert durch den Open-Access-Publikationsfonds 2015/2016 der Westfälischen Wilhelms-Universität Münster (WWU Münster). 
506 0 |a free access 
510 0 |a PLoS ONE 10 (2015) 11, e0143755, 1-21 
520 3 |a Background: No reliable predictors of susceptibility to gemcitabine chemotherapy exist in pancreatic ductal adenocarcinoma (PDAC). MicroRNAs (miR) are epigenetic gene regulators with tumorsuppressive or oncogenic roles in various carcinomas. This study assesses chemoresistant PDAC for its specific miR expression pattern. Methods: Gemcitabine-resistant variants of two mutant p53 human PDAC cell lines were established. Survival rates were analyzed by cytotoxicity and apoptosis assays. Expression of 1733 human miRs was investigated by microarray and validated by qRT-PCR. After in-silico analysis of specific target genes and proteins of dysregulated miRs, expression of MRP-1, Bcl-2, mutant p53, and CDK1 was quantified by Western blot. Results: Both established PDAC clones showed a significant resistance to gemcitabine (p<0.02) with low apoptosis rate (p<0.001) vs. parental cells. MiR-screening revealed significantly upregulated (miR-21, miR-99a, miR-100, miR-125b, miR-138, miR-210) and downregulated miRs (miR-31*, miR-330, miR-378) in chemoresistant PDAC (p<0.05). Bioinformatic analysis suggested involvement of these miRs in pathways controlling cell death and cycle. MRP-1 (p<0.02) and Bcl-2 (p<0.003) were significantly overexpressed in both resistant cell clones and mutant p53 (p = 0.023) in one clone. Conclusion: Consistent miR expression profiles, in part regulated by mutant TP53 gene, were identified in gemcitabine-resistant PDAC with significant MRP-1 and Bcl-2 overexpression. These results provide a basis for further elucidation of chemoresistance mechanisms and therapeutic approaches to overcome chemoresistance in PDAC. 
521 |a specialized 
540 |a CC BY 4.0  |u http://creativecommons.org/licenses/by/4.0/ 
655 7 |2 DRIVER Types  |a Artikel 
655 7 |2 DCMI Types  |a Text 
700 1 |a Mardin, Wolf Arif Mithat  |0 http://d-nb.info/gnd/143588605  |4 aut 
700 1 |a Seggewiß, Jochen  |0 http://d-nb.info/gnd/139649085  |4 aut 
700 1 |a Ströse, Anda Jana  |0 http://d-nb.info/gnd/1105054322  |4 aut 
700 1 |a Matuszcak, Christiane  |0 http://d-nb.info/gnd/1099117100  |4 aut 
700 1 |a Hummel, Richard  |0 http://d-nb.info/gnd/13014813X  |4 aut 
700 1 |a Senninger, Norbert  |u FB 05: Medizinische Fakultät  |0 http://d-nb.info/gnd/1112625585  |4 aut 
700 1 |a Mees, Sören Torge  |u FB 05: Medizinische Fakultät  |0 http://d-nb.info/gnd/128717971  |4 aut 
700 1 |a Haier, Jörg  |u FB 05: Medizinische Fakultät  |0 http://d-nb.info/gnd/171443683  |4 aut 
856 4 0 |3 Zum Volltext  |q text/html  |u https://nbn-resolving.de/urn:nbn:de:hbz:6-76229530002  |u urn:nbn:de:hbz:6-76229530002 
856 4 0 |3 Zum Volltext  |q application/pdf  |u https://repositorium.uni-muenster.de/document/miami/8d7366b3-72ba-41ad-8654-0cc02ab7b687/journal.pone.0143755.PDF